Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. 2010

J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
Institute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany. jelias@hygiene.uni-wuerzburg.de

Pseudomonas aeruginosa is well adapted to the hospital setting and can cause a wide array of nosocomial infections that occasionally culminate in recalcitrant outbreaks. In the present study, we describe the first nosocomial outbreak of infection caused by bla(VIM-2)-positive P. aeruginosa in Germany. In November and December 2007, highly resistant P. aeruginosa isolates were recovered from the urine of 11 patients in the Department of Urology of a University Hospital. Bacterial isolates were typed by multilocus sequence typing and screened for known metallo-β-lactamase (MBL) genes by PCR. Environmental sources of transmission were tested for bacterial contamination using surveillance cultures. Furthermore, a matched case-control study was performed in search of medical procedures significantly associated with case status. Typing of recovered isolates confirmed VIM-2 MBL-producing P. aeruginosa of sequence type 175 in all cases. Surveillance cultures did not lead to the identification of an environmental source of the outbreak strain. Case-control analysis revealed retrograde urography as the only exposure significantly associated with case status. The analyses suggest the transmission of a single clone of VIM-2 MBL-producing P. aeruginosa leading to the infection of 11 patients within 47 days. Events in temporal proximity to retrograde urographies appear to have facilitated infection in the majority of cases. Department-specific infection control measures, including reinforced hygiene procedures during retrograde urography, quickly terminated the outbreak.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004783 Environmental Microbiology The study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man. Microbiology, Environmental
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.

Related Publications

J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
October 2011, Diagnostic pathology,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
July 2012, The Journal of antimicrobial chemotherapy,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
August 2005, Antimicrobial agents and chemotherapy,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
July 2010, Journal of medical microbiology,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
January 2008, The Journal of hospital infection,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
June 2011, International journal of antimicrobial agents,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
November 2010, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
December 2013, The Journal of antimicrobial chemotherapy,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
April 2019, Journal of infection in developing countries,
J Elias, and C Schoen, and G Heinze, and G Valenza, and E Gerharz, and H Gerharz, and U Vogel
June 2011, Journal of medical microbiology,
Copied contents to your clipboard!